Nanomaterial-Based Drug Delivery Systems

Dr. Chandrakantsing Pardeshi holds Ph.D. degree in Pharmaceutical Sciences from Kavayitri Bahinabai Chaudhari North Maharashtra University (KBC NMU, Jalgaon, India). He has been involved in the development of various nanocarrier formulations for direct nose to brain drug delivery since last decade. His active areas of research includes nasal drug delivery, development of nanoparticulate formulations for pharmaceutical and biomedical applications, and polymer modifications for utilization in drug delivery. Currently, he is inventing new drug administration devices for nasal and pulmonary applications in his laboratory. He has authored more than 52 peer-reviewed international research and review articles, 1 edited book, 21 book chapters, 19 conference presentations, 1 funded research project from UGC, Government of India. He has filed 2 Indian patent applications on novel neuronanoemulsion formulations for direct nose to brain drug delivery. He is an active referee for several reputedrefereed journals. He is a recipient of the Gold Medal from KBC NMU (Jalgaon, India), Excellence Award from Indian Drug Manufacturer's Association (Mumbai, India), Young Faculty Award (Kolkata, India). He has been enlisted in the Top 2% Scientists in the World Ranking released by Stanford University (USA) for two consecutive years (2021 & 2022).

Section-I: Introduction to nanomaterials for drug delivery.- Introduction to Nanomaterials for drug delivery.- Section-II: Nanomaterials-based drug delivery systems for Therapeutic applications.- Polymer-based nanomaterials.- Lipid-based nanomaterials.- Vesicular nanomaterials.- Hybrid nanomaterials.- Section-III: Nanomaterials-based drug delivery systems for Theranostic applications.- Magnetic nanoparticles.- Quantum dots.- Upconversion nanoparticles.- Gold nanoparticles.- Carbon-based nanoparticles.- Graphene-based nanoparticles.- Section-IV: Nanomaterials toxicity & clinical translation.- Nanotoxicology: an overview.- Patenting nanomaterials: Regulatory aspects.- Clinical perspectives: Translating nanomaterials from laboratory to clinic.